Thyroid Cancer Trial, Recruiting NCT06220656 Sponsor: Dartmouth-Hitchcock Medical Center Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT06220656
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older.
  • People who are able and willing to give informed consent, or who have a designated person (such as a family member or legal representative) who can give consent on their behalf.
  • People whose thyroid nodule is not causing symptoms such as difficulty swallowing, or is not visibly noticeable or bothersome.
  • People whose thyroid nodule has been rated as TI-RADS 4 or 5 on imaging — a scoring system used by doctors to assess the risk level of thyroid nodules (confirm with trial site if unsure of your rating).
  • People whose thyroid nodule measures 2 centimetres or smaller at its widest point.
  • People who are already being considered for a biopsy (a procedure to sample tissue from the nodule).
  • People with a past history of a specific type of thyroid cancer called papillary thyroid cancer.
  • For the interview/recording portion of the study: people who are willing to have conversations audio-recorded and/or to be interviewed by the research team.

Who may not be able to join:

  • Adults who are not able to give informed consent and do not have a surrogate available to do so.
  • People for whom a biopsy is not being considered by their doctor.
  • People with a history of any type of thyroid cancer other than papillary thyroid cancer.
  • People who have had radiation treatment to the neck at any point.
  • People who no longer have a thyroid gland (due to surgical removal) or who only have thyroid tissue located at the base of the tongue rather than in the normal position in the neck.
  • People whose ultrasound scan shows that the nodule is growing into the airway, pressing on or growing into a nearby nerve called the recurrent laryngeal nerve, or extending beyond the thyroid gland.
  • People who have cancer that has spread to the lymph nodes in the neck (confirmed by biopsy if the ultrasound raises concern) or to other parts of the body.
  • People who have already had a biopsy performed on the specific nodule being considered for this study.
  • For the interview/recording portion of the study: people who are not willing to have conversations audio-recorded or to be interviewed by the research team.
  • For staff participants: staff members who are not willing to have recruitment conversations recorded or to participate in interviews with the research team.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Louise Davies, MD, MS, Dartmouth-Hitchcock Medical Center

Phone: (603) 305-3529

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of Anxiety at 6 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov